HYTN Innovations Boosts Psychedelic Manufacturing with Acquisition
Company Announcements

HYTN Innovations Boosts Psychedelic Manufacturing with Acquisition

Story Highlights

HYTN Innovations Inc (TSE:HYTN) has released an update.

HYTN Innovations Inc. has completed its acquisition of Prism Scientific Labs, aiming to enhance its psychedelic compound manufacturing capabilities, particularly in the field of psilocybin. The deal secures HYTN exclusive rights to Prism’s intellectual property and technologies that promise to boost mushroom yield and potency. This strategic move aligns with HYTN’s aspiration to be a leader in supplying psychoactive compounds for clinical use in federally regulated markets.

For further insights into TSE:HYTN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskHYTN Innovations Secures GMP Certification for Global Distribution
TipRanks Canadian Auto-Generated NewsdeskHYTN Innovations Broadens Reach with Latest Acquisition
TipRanks Canadian Auto-Generated NewsdeskHYTN Innovations Expands Global Reach with 4C LABS
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App